Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sucha Sudarsanam

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Current Opinion in Drug Discovery & Development|January 5, 2010
Functional consequences of mTOR inhibitionSucha Sudarsanam, Dale E Johnson
Biochemical and Biophysical Research Communications|September 22, 2006
Profiling human phosphodiesterase genes and splice isoformsJonathan Bingham, Sucha Sudarsanam, Subha Srinivasan
Current Drug Discovery Technologies|October 26, 2011
Translational biology approach to identify causative factors for rare toxicities in humans and animalsE Dale Johnson, Sucha Sudarsanam, Jonathan Bingham, et al.
Trends in Biochemical Sciences|October 9, 2002
Evolution of protein kinase signaling from yeast to manGerard Manning, Gregory D Plowman, Tony Hunter, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 23, 2012
BiomarkersHarmony Larson, Elena Chan, Sucha Sudarsanam, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2004
The mouse kinome: discovery and comparative genomics of all mouse protein kinasesSean Caenepeel, Glen Charydczak, Sucha Sudarsanam, et al.
Current Opinion in Drug Discovery & Development|January 5, 2010
Interactions between traditional Chinese medicines and Western therapeuticsElena Chan, Marisela Tan, Jianni Xin, et al.
Journal of Clinical Pathology|October 3, 2018
A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignanciesCory Batenchuk, Maher Albitar, Kim Zerba, et al.
Oncotarget|March 24, 2018
Correlation of <i>MET</i> gene amplification and <i>TP53</i> mutation with PD-L1 expression in non-small cell lung cancerMaher Albitar, Sucha Sudarsanam, Wanlong Ma, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 15, 2019
Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 62,896 casesDennis P O'Malley, Yuhang Yang, Saskia Boisot, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Current Opinion in Drug Discovery & Development|January 5, 2010
Functional consequences of mTOR inhibitionSucha Sudarsanam, Dale E Johnson
Biochemical and Biophysical Research Communications|September 22, 2006
Profiling human phosphodiesterase genes and splice isoformsJonathan Bingham, Sucha Sudarsanam, Subha Srinivasan
Current Drug Discovery Technologies|October 26, 2011
Translational biology approach to identify causative factors for rare toxicities in humans and animalsE Dale Johnson, Sucha Sudarsanam, Jonathan Bingham, et al.
Trends in Biochemical Sciences|October 9, 2002
Evolution of protein kinase signaling from yeast to manGerard Manning, Gregory D Plowman, Tony Hunter, et al.
Methods in Molecular Biology (Clifton, N.J.)|October 23, 2012
BiomarkersHarmony Larson, Elena Chan, Sucha Sudarsanam, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 4, 2004
The mouse kinome: discovery and comparative genomics of all mouse protein kinasesSean Caenepeel, Glen Charydczak, Sucha Sudarsanam, et al.
Current Opinion in Drug Discovery & Development|January 5, 2010
Interactions between traditional Chinese medicines and Western therapeuticsElena Chan, Marisela Tan, Jianni Xin, et al.
Journal of Clinical Pathology|October 3, 2018
A real-world, comparative study of FDA-approved diagnostic assays PD-L1 IHC 28-8 and 22C3 in lung cancer and other malignanciesCory Batenchuk, Maher Albitar, Kim Zerba, et al.
Oncotarget|March 24, 2018
Correlation of <i>MET</i> gene amplification and <i>TP53</i> mutation with PD-L1 expression in non-small cell lung cancerMaher Albitar, Sucha Sudarsanam, Wanlong Ma, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 15, 2019
Immunohistochemical detection of PD-L1 among diverse human neoplasms in a reference laboratory: observations based upon 62,896 casesDennis P O'Malley, Yuhang Yang, Saskia Boisot, et al.
Pageof 2